Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the earnings per share (EPS) high or low?
The earnings per share (EPS) of -1.68 is 9980% below its 5-year average of -0.02, near the low end of its 5-year range (-1.68–1.95).
315.38% below its 12-month average of 0.78.
Reported quarterly EPS; no daily interpolation. Q2 FY2026 (2026-06-30): -0.52.
EPS growth vs the same fiscal quarter in the prior fiscal year, last 36 comparable quarters.
FMP quote price / unrounded diluted EPS from four consecutive issuer fiscal quarters Quote observation: 2026-10-06T13:25:45.497Z. Historical observations retain their original dates. Historical series through 2025-12-31.
EARNINGS PER SHARE (EPS)
-1.68
EARNINGS PER SHARE (EPS) AVG TTM
0.78
EARNINGS PER SHARE (EPS) AVG 3Y
0.08
EARNINGS PER SHARE (EPS) AVG 5Y
-0.02
EARNINGS PER SHARE (EPS) AVG 10Y
-0.53
EARNINGS PER SHARE (EPS) AVG 15Y
-0.72
EARNINGS PER SHARE (EPS) AVG 20Y
N/A
CURRENT VS TTM AVG
-315.38%
CURRENT VS 3Y AVG
-2267.74%
CURRENT VS 5Y AVG
-9980.00%
CURRENT VS 10Y AVG
-218.62%
CURRENT VS 15Y AVG
-133.33%
CURRENT VS 20Y AVG
N/A
BioStem Technologies, Inc.
Market Cap
$46.79M
Earnings Per Share (EPS)
-1.68
TTM Avg
0.78
3Y Avg
0.08
5Y Avg
-0.02
Market Cap
$45.20M
Earnings Per Share (EPS)
-0.73
TTM Avg
-1.48
3Y Avg
-1.47
5Y Avg
-1.37
Market Cap
$49.50M
Earnings Per Share (EPS)
-2.83
TTM Avg
-3.12
3Y Avg
-4.06
5Y Avg
-22.86
Market Cap
$49.96M
Earnings Per Share (EPS)
-3.55
TTM Avg
-4.16
3Y Avg
-5.92
5Y Avg
-5.28
Market Cap
$50.25M
Earnings Per Share (EPS)
-0.67
TTM Avg
-1.36
3Y Avg
-1.71
5Y Avg
-1.31
Market Cap
$50.51M
Earnings Per Share (EPS)
N/A
TTM Avg
-30.18
3Y Avg
-88.49
5Y Avg
-66.35
Market Cap
$51.12M
Earnings Per Share (EPS)
-8.95
TTM Avg
-8.42
3Y Avg
-12.89
5Y Avg
-25.33
Market Cap
$42.41M
Earnings Per Share (EPS)
0.69
TTM Avg
-0.78
3Y Avg
-1.53
5Y Avg
-2.71
| NAME | MARKET CAP | EARNINGS PER SHARE (EPS) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| BioStem Technologies, Inc. (BSEM) | $46.79M | -1.68 | 0.78 | 0.08 | -0.02 |
| Werewolf Therapeutics, Inc. (HOWL)vs › | $45.20M | -0.73 | -1.48 | -1.47 | -1.37 |
| biote Corp. (BTMD)vs › | $49.40M | 0.12 | 0.48 | 0.24 | 1.52 |
| Celularity Inc. (CELU)vs › | $49.50M | -2.83 | -3.12 | -4.06 | -22.86 |
| Clene Inc. (CLNN)vs › | $49.96M | -3.55 | -4.16 | -5.92 | -5.28 |
| Envoy Medical, Inc. (COCH)vs › | $50.25M | -0.67 | -1.36 | -1.71 | -1.31 |
| Apollomics, Inc. (APLM)vs › | $50.51M | N/A | -30.18 | -88.49 | -66.35 |
| Dogwood Therapeutics, Inc. (DWTX)vs › | $51.12M | -8.95 | -8.42 | -12.89 | -25.33 |
| DarioHealth Corp. (DRIO)vs › | $42.41M | 0.69 | -0.78 | -1.53 | -2.71 |
| eXoZymes, Inc. (EXOZ)vs › | $51.23M | -1.20 | -0.91 | -0.56 | -0.48 |
Trailing EPS (TTM)
$-1.68
Forward EPS (Est.)
$-1.90
P/E Ratio
N/A
Formula: EPS = Net Income / Weighted Average Shares Outstanding
Why EPS matters:
EPS (Earnings Per Share) represents the portion of a company's profit allocated to each outstanding share. Higher EPS indicates greater profitability on a per-share basis.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | EARNINGS PER SHARE (EPS) |
|---|---|
| 2025-12-31 | -0.39 |
| 2024-12-31 | 1.95 |
| 2023-12-31 | -0.62 |
| 2022-12-31 | -0.63 |
| 2021-12-31 | -0.15 |
| 2020-12-31 | -0.26 |
| 2019-12-31 | -0.69 |
| 2018-12-31 | -0.94 |
| 2017-12-31 | -0.95 |
| 2016-12-31 | -1.07 |
| 2015-12-31 | -2.05 |
| 2014-12-31 | -0.21 |
| 2013-12-31 | -3.35 |
| 2012-12-31 | -160.89 |
| 2011-12-31 | -25.43 |
| 2010-12-31 | -14.62 |
